AU2006293814B2 - Method for obtaining human smooth muscular cells and uses thereof - Google Patents

Method for obtaining human smooth muscular cells and uses thereof Download PDF

Info

Publication number
AU2006293814B2
AU2006293814B2 AU2006293814A AU2006293814A AU2006293814B2 AU 2006293814 B2 AU2006293814 B2 AU 2006293814B2 AU 2006293814 A AU2006293814 A AU 2006293814A AU 2006293814 A AU2006293814 A AU 2006293814A AU 2006293814 B2 AU2006293814 B2 AU 2006293814B2
Authority
AU
Australia
Prior art keywords
cells
medium
human
culture
muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006293814A
Other languages
English (en)
Other versions
AU2006293814A1 (en
Inventor
Marie-Noelle Lacassagne
Sophie Le Ricousse
Jean-Pierre Marolleau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique - Hôpitaux de Paris
Vessels and Blood Institute
Original Assignee
Assistance Publique - Hôpitaux de Paris
Vessels and Blood Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique - Hôpitaux de Paris, Vessels and Blood Institute filed Critical Assistance Publique - Hôpitaux de Paris
Publication of AU2006293814A1 publication Critical patent/AU2006293814A1/en
Application granted granted Critical
Publication of AU2006293814B2 publication Critical patent/AU2006293814B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0661—Smooth muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1323—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from skeletal muscle cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Excavating Of Shafts Or Tunnels (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
AU2006293814A 2005-09-19 2006-09-19 Method for obtaining human smooth muscular cells and uses thereof Ceased AU2006293814B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0509557 2005-09-19
FR0509557A FR2890977A1 (fr) 2005-09-19 2005-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications
PCT/FR2006/002144 WO2007034069A1 (fr) 2005-09-19 2006-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications

Publications (2)

Publication Number Publication Date
AU2006293814A1 AU2006293814A1 (en) 2007-03-29
AU2006293814B2 true AU2006293814B2 (en) 2011-09-29

Family

ID=36587333

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006293814A Ceased AU2006293814B2 (en) 2005-09-19 2006-09-19 Method for obtaining human smooth muscular cells and uses thereof

Country Status (10)

Country Link
US (1) US20090269310A1 (cg-RX-API-DMAC7.html)
EP (1) EP1934333B9 (cg-RX-API-DMAC7.html)
JP (1) JP2009508511A (cg-RX-API-DMAC7.html)
CN (1) CN101310013B (cg-RX-API-DMAC7.html)
AT (1) ATE531791T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006293814B2 (cg-RX-API-DMAC7.html)
CA (1) CA2622916A1 (cg-RX-API-DMAC7.html)
FR (1) FR2890977A1 (cg-RX-API-DMAC7.html)
IL (1) IL190289A0 (cg-RX-API-DMAC7.html)
WO (1) WO2007034069A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2909559B1 (fr) * 2006-12-06 2012-09-07 Inst Vaisseaux Et Du Sang Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
ES2689932T3 (es) * 2008-11-04 2018-11-16 Inregen Construcciones de armazones de células
KR102780297B1 (ko) * 2017-12-14 2025-03-12 이노바셀 바이오테크놀로지 아게 근육 유래 세포를 수득하는 방법
CN112119155A (zh) * 2018-05-08 2020-12-22 苏黎士大学 用于无异种产生hMPC群的方法
KR20220002315A (ko) * 2019-03-22 2022-01-06 이노바셀 아게 유도된 평활근 세포를 수득하는 방법
CN120418415A (zh) * 2022-12-28 2025-08-01 因特斯迪姆株式会社 细胞组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2810045B1 (fr) * 2000-06-07 2004-09-03 Assist Publ Hopitaux De Paris Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
US20040247575A1 (en) * 2003-06-03 2004-12-09 Caplice Noel M. Smooth muscle progenitor cells

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Le Ricousse-Roussanne et al (2004) Cardiovascular Research. Vol. 62, pps 176-184 *
Simper etal (2002) Circulation, Vol, 106, pps 1199-1204 *

Also Published As

Publication number Publication date
CN101310013B (zh) 2011-09-07
WO2007034069A1 (fr) 2007-03-29
CN101310013A (zh) 2008-11-19
IL190289A0 (en) 2011-08-01
US20090269310A1 (en) 2009-10-29
CA2622916A1 (fr) 2007-03-29
FR2890977A1 (fr) 2007-03-23
EP1934333B9 (fr) 2012-05-02
EP1934333B1 (fr) 2011-11-02
ATE531791T1 (de) 2011-11-15
EP1934333A1 (fr) 2008-06-25
JP2009508511A (ja) 2009-03-05
AU2006293814A1 (en) 2007-03-29

Similar Documents

Publication Publication Date Title
US7582292B2 (en) Adipose tissue derived stromal cells for the treatment of neurological disorders
DE60132429T2 (de) Pluripotente aus von fettgewebe stammenden stromazellen erzeugte stammzellen und deren verwendung
Mimeault et al. Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies
Torrente et al. Intraarterial injection of muscle-derived CD34+ Sca-1+ stem cells restores dystrophin in mdx mice
Zhang et al. SDF‐1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction
US20050169896A1 (en) Bone marrow transplantation for treatment of stroke
Watanabe et al. A human neural stem cell line provides neuroprotection and improves neurological performance by early intervention of neuroinflammatory system
AU2013211934B2 (en) Methods and compositions for modulating angiogenesis and vasculogenesis
Itescu et al. Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function
WO2016161290A1 (en) Methods and compositions for stimulation of cell proliferation and provision of biologically active mixtures of fgf2 isoforms
US20090269310A1 (en) Method for obtaining human smooth muscular cells and uses thereof
KR102630220B1 (ko) 유도만능줄기세포-유래 중간엽 줄기세포 전구세포로부터 유래된 엑소좀을 포함하는 신장 질환의 예방 또는 치료용 조성물
Itescu et al. Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function
Wang et al. Reconstitute the damaged heart via the dual reparative roles of pericardial adipose-derived flk-1+ stem cells
CN110551688B (zh) 一种诱导体细胞重编程为造血干/祖细胞且促进造血干/祖细胞体外扩增的组合物及其应用
JP2011015609A (ja) 内皮前駆細胞(epc)の増殖・分化誘導方法
Kim et al. Intracellular transduction of TAT-Hsp27 fusion protein enhancing cell survival and regeneration capacity of cardiac stem cells in acute myocardial infarction
JP2009508511A5 (cg-RX-API-DMAC7.html)
Hattori et al. Intracranial transplantation of monocyte‐derived multipotential cells enhances recovery after ischemic stroke in rats
Le Ricousse-Roussanne et al. Ex vivo generation of mature and functional human smooth muscle cells differentiated from skeletal myoblasts
WO2001048150A1 (en) Cells capable of differentiating into heart muscle cells
WO2007047963A2 (en) Use of bone-marrow derived stem cells to treat ischemia
US20190382728A1 (en) Menstrual Blood Derived Angiogenesis Stimulatory Cells
WO2007084487A2 (en) Pericytes for use as stem cells
US20090304650A1 (en) Repair of the Bone Marrow Vasculature

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired